The incidence of rare and compound mutations of EGFR in non-small cell lung cancer and their potential clinical significance

被引：0
|
作者：
Liang, Sharron [1 ]
Wang, Bin [1 ]
Chin, Venessa [2 ,3 ,4 ]
Huang, Min [1 ]
Wong, Stephen [1 ]
Riley, Denise [1 ]
Luo, Ruby [1 ]
Barrett, Wade [1 ]
Yang, Tao [1 ]
Qiu, Min Ru [1 ,4 ]
机构：
[1] St Vincents Hosp, Anat Pathol Dept SydPath, Sydney, NSW, Australia
[2] St Vincents Hosp, Dept Med Oncol, Sydney, NSW, Australia
[3] Garvan Inst Med Res, Sydney, NSW, Australia
[4] Univ New South Wales, Sydney, NSW, Australia
来源：
RESPIROLOGY | 2023年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
30
引用
收藏
页码：28 / 29
页数：2
相关论文
共 50 条
  • [41] Clinical significance of the apoptotic index in non-small cell lung cancer
    Dworakowska, Dorota
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2005, 9 (09): : 380 - 385
  • [42] Clinical significance of TILs subtypes in non-small cell lung cancer
    Schalper, Kurt A.
    Brown, Jason
    McLaughlin, Joseph Francis
    Herbst, Roy S.
    Rimm, David L.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [43] A Case of Non-Small Cell Lung Cancer with Mutually Exclusive EGFR and KRAS Mutations
    Tushir, Abhimanyu
    Akhtar, Israh
    Seth, Anjali
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2025, 47 (01)
  • [44] Acquired EGFR-resistant mutations in non-small cell lung cancer (NSCLC).
    Raez, Luis E.
    Baca, Yasmine
    Nieva, Jorge J.
    Mamdani, Hirva
    Lopes, Gilberto
    Borghaei, Hossein
    Socinski, Mark A.
    Nabhan, Chadi
    Wozniak, Antoinette J.
    Vanderwalde, Ari M.
    Uribe, Carlos Carracedo
    Khan, Hina
    Liu, Stephen V.
    Nagasaka, Misako
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [45] CLINICOPATHOLOGICAL FEATURES IN NON-SMALL CELL LUNG CANCER PATIENTS WITH EGFR AND KRAS MUTATIONS
    Nishii, Teppei
    Yokose, Tomoyuki
    Miyagi, Yohei
    Ito, Hiroyuki
    Watanabe, Masato
    Imamura, Naoko
    Isaka, Tetsuya
    Imai, Kentaro
    Karino, Fumi
    Murakami, Shuji
    Kondo, Tetsuro
    Saito, Haruhiro
    Oshita, Fumihiro
    Yamada, Kouzo
    Nakayama, Haruhiko
    Masuda, Munetaka
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S965 - S965
  • [46] In Non-small Cell Lung Cancer, Can Radiomic Features Predict EGFR Mutations?
    Liu, Jiayan
    Liu, Lin
    Ma, Yue
    Xue, Kaiming
    Zhou, Zhe
    Zhang, Mengchao
    2019 IEEE INTERNATIONAL CONFERENCE ON MECHATRONICS AND AUTOMATION (ICMA), 2019, : 2180 - 2184
  • [47] The prevalence of EGFR mutations in non-small cell lung cancer in an unselected Caucasian population
    Skov, Birgit G.
    Hogdall, Estrid
    Clementsen, Paul
    Krasnik, Mark
    Larsen, Klaus Richter
    Sorensen, Jens Benn
    Skov, Torsten
    Mellemgaard, Anders
    APMIS, 2015, 123 (02) : 108 - 115
  • [48] Sequential treatment in advanced non-small cell lung cancer harboring EGFR mutations
    Hsu, Ping-Chih
    Chang, John Wen-Cheng
    Chang, Ching-Fu
    Huang, Chen-Yang
    Yang, Cheng-Ta
    Kuo, Chih-Hsi Scott
    Fang, Yueh-Fu
    Wu, Chiao-En
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2022, 16
  • [49] A comprehensive review of uncommon EGFR mutations in patients with non-small cell lung cancer
    Tu, Hai-Yan
    Ke, E-E
    Yang, Jin-Ji
    Sun, Yue-Li
    Yan, Hong-Hong
    Zheng, Ming-Ying
    Bai, Xiao-Yan
    Wang, Zhen
    Su, Jian
    Chen, Zhi-Hong
    Zhang, Xu-Chao
    Dong, Zhong-Yi
    Wu, Si-Pei
    Jiang, Ben-Yuan
    Chen, Hua-Jun
    Wang, Bin-Chao
    Xu, Chong-Rui
    Zhou, Qing
    Mei, Ping
    Luo, Dong-Lan
    Zhong, Wen-zhao
    Yang, Xue-Ning
    Wu, Yi-Long
    LUNG CANCER, 2017, 114 : 96 - 102
  • [50] Lower Risk of Hypercoagulability in Non-Small Cell Lung Cancer Patients with EGFR Mutations
    Ohara, S.
    Suda, K.
    Takemoto, T.
    Nishino, M.
    Chiba, M.
    Fujino, T.
    Hamada, A.
    Koga, T.
    Soh, J.
    Misudomi, T.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S653 - S653
12345